APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics.

Saved in:
Bibliographic Details
Title: APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics.
Authors: Abushakra S; Alzheon, Inc. Framingham Massachusetts USA., Porsteinsson AP; Alzheimer's Disease Care, Research & Education Program, Department of Psychiatry University of Rochester Rochester New York USA., Sabbagh M; Barrow Neurological Institute and St. Joseph's Hospital Phoenix Arizona USA., Watson D; Alzheimer's Research and Treatment Center Wellington Florida USA., Power A; Alzheon, Inc. Framingham Massachusetts USA., Liang E; Alzheon, Inc. Framingham Massachusetts USA., MacSweeney E; Re:Cognition Health London UK., Boada M; Ace Alzheimer Center Barcelona, International University of Catalunya, Barcelona, Spain and Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III Madrid Spain., Flint S; Alzheon, Inc. Framingham Massachusetts USA., McLaine R; Alzheon, Inc. Framingham Massachusetts USA., Kesslak JP; Alzheon, Inc. Framingham Massachusetts USA., Hey JA; Alzheon, Inc. Framingham Massachusetts USA., Tolar M; Alzheon, Inc. Framingham Massachusetts USA.
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2024 Aug 13; Vol. 10 (3), pp. e12498. Date of Electronic Publication: 2024 Aug 13 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2352-8737
DOI:10.1002/trc2.12498